Skip to main content
. 2015 Apr 10;35(2):156–164. doi: 10.1007/s40846-015-0032-9

Fig. 8.

Fig. 8

Tumor volume growth rates for treatment with non-targeting MBs, targeting MBs, and targeting MBs combined with pUS treatment